Neo-adjuvant Treatment With Temozolomide and Bevacizumab Previous to Temozolomide Plus Radiation Plus Bevacizumab Therapy in Unresectable Glioblastoma
Clinical trial NCT01102595 · COMPLETED
Trial details
- NCT number
- NCT01102595
- Sponsor
- Grupo Español de Investigación en Neurooncología
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2013-10-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.